Purpose: This study uses data from the ImproveCareNow Registry to examine the duration and effectiveness of Adalimumab therapy in pediatric Crohn’s Disease within the ICN network. This knowledge is an important step in learning how to optimize the use of Adalimumab.
Funding Source: AbbVie (2016)
Study Period: 2015-2017
Recruitment Status: This study makes use of existing data in the ICN registry.
Contact: ImproveCareNow Research
More Information:
Putting Data to Work to Answer Questions: Evaluation of Adalimumab Effectiveness